How Patel was paid
$3.7M in total for 2025, as reported in the Summary Compensation Table. Equity awards are valued at grant, not at what they turned out to be worth.
Named executive officers
| Executive | Salary | Stock | Options | Incentive | Other | Total |
|---|---|---|---|---|---|---|
| Sushil PatelChief Executive Officer | $600,000 | $1,288,359 | $1,345,900 | $450,000 | $13,402 | $3,697,661 |
| Emily HillChief Financial Officer | $516,500 | $412,241 | $430,688 | $235,524 | — | $1,594,953 |
| Konstantinos XynosChief Medical Officer | $516,500 | $412,241 | $430,688 | $253,085 | $12,351 | $1,624,865 |
What changed and why
- $3.7M$3,697,661 was CEO Sushil Patel’s total compensation, up from $2,063,097 in 2024.
- $600K$600,000 was Patel’s fiscal 2025 base salary after joining as full-time CEO on April 1, 2024.
- 125%125% of target was Patel’s annual bonus payout, producing a $450,000 cash bonus.
- 60%60% of base salary was Patel’s target annual bonus opportunity for fiscal 2025.
- $1.3M$1,288,359 in stock awards and $1,345,900 in option awards comprised Patel’s reported equity compensation.
- 100%$644,180 was the grant-date fair value of Patel’s performance-based RSUs at 100% attainment.
Other Replimune Group proxy statements
- 2026 proxy statement
Sushil Patel paid $5.8M (+58% on the year).
Filed Jul 29, 2026
About this page
Figures are automated and can be wrong; check the filing for the exact numbers. Totals follow SEC rules, which value stock and option awards at grant. Read the DEF 14A proxy statement for footnotes and the compensation committee's full reasoning.